Mediterr J Rheumatol 2020;31(4):378-81
Searching for Possible Links between Alzheimer’s Disease and Systemic Sclerosis
Authors Information

1. Department of Neurology, and 2. Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly, University General Hospital of Larissa, Larissa, Greece

Efthymios Dardiotis,  Dimitrios P. Bogdanos

  1. Dardiotis E, Kosmidis MH, Yannakoulia M, Hadjigeorgiou GM, Scarmeas N. The Hellenic Longitudinal Investigation of Aging and Diet (HELIAD): rationale, study design, and cohort description. Neuroepidemiology 2014;43:9-14.
  2. Kosmidis MH, Vlachos GS, Anastasiou CA, Yannakoulia M, Dardiotis E, Hadjigeorgiou G, et al. Dementia Prevalence in Greece: The Hellenic Longitudinal Investigation of Aging and Diet (HELIAD). Alzheimer Dis Assoc Disord 2018;32:232-9.
  3. Arseniou S, Siokas V, Aloizou AM, Stamati P, Mentis AA, Tsouris Z, et al.  SLC2A3 rs12842 polymorphism and risk for Alzheimer's disease. Neurol Res 2020;42:853-61.
  4. Siokas V, Aslanidou P, Aloizou AM, Peristeri E, Stamati P, Liampas I, et al. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer's Disease? J Mol Neurosci 2020;70:851-60.
  5. Stamati P, Siokas V, Aloizou AM, Karampinis E, Arseniou S, Rakitskii VN, et al. Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer's Disease Risk? J Mol Neurosci 2019;69:343-50.
  6. Presta I, Vismara M, Novellino F, Donato A, Zaffino P, Scali E, et al. Innate Immunity Cells and the Neurovascular Unit. Int J Mol Sci 2018 Dec 3;19(12):3856.
  7. Shi Y, Holtzman DM. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol 2018 Dec;18(12):759-72.
  8. D'Andrea MR. Add Alzheimer's disease to the list of autoimmune diseases. Med Hypotheses 2005;64:458-63.
  9. Flanagan EP, McKeon A, Lennon VA, Boeve BF, Trenerry MR, Tan KM, et al. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc 2010;85:881-97.
  10. D'Andrea MR. Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease. Brain Res 2003;982:19-30.
  11. Castellani G, Schwartz M. Immunological Features of Non-neuronal Brain Cells: Implications for Alzheimer's Disease Immunotherapy. Trends Immunol 2020;41:794-804.
  12. Lio D, Licastro F, Scola L, Chiappelli M, Grimaldi LM, Crivello A, et al. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun 2003;4:234-8.
  13. Lodygin D, Hermann M, Schweingruber N, Flugel-Koch C, Watanabe T, Schlosser C, et al. beta-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature 2019;566:503-8.
  14. Monsonego A, Zota V, Karni A, Krieger JI, Bar-Or A, Bitan G, et al. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J Clin Invest 2003;112:415-22.
  15. Mietelska-Porowska A, Wojda U. T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers. J Immunol Res 2017;4626540.
  16. Merlini M, Kirabali T, Kulic L, Nitsch RM, Ferretti MT. Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study. Neurodegener Dis 2018;18:49-56.
  17. Markousis-Mavrogenis G, Mitsikostas DD, Koutsogeorgopoulou L, Dimitroulas T, Katsifis G, Argyriou P, et al. Combined Brain-Heart Magnetic Resonance Imaging in Autoimmune Rheumatic Disease Patients with Cardiac Symptoms: Hypothesis Generating Insights from a Cross-sectional Study. J Clin Med 2020 Feb 6;9(2):447.
  18. Dhanwani R, Pham J, Premlal ALR, Frazier A, Kumar A, Pero ME, et al. T Cell Responses to Neural Autoantigens Are Similar in Alzheimer's Disease Patients and Age-Matched Healthy Controls. Front Neurosci 2020;14:874.
  19. Schwartz M, Baruch K. Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation. J Autoimmun 2014;54:8-14.
  20. Polanco JC, Li C, Bodea LG, Martinez-Marmol R, Meunier FA, Gotz J. Amyloid-beta and tau complexity - towards improved biomarkers and targeted therapies. Nat Rev Neurol 2018;14:22-39.
  21. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010;362:329-44.
  22. Jevtic S, Sengar AS, Salter MW, McLaurin J. The role of the immune system in Alzheimer disease: Etiology and treatment. Ageing Res Rev 2017;40:84-94.
  23. Molteni M, Rossetti C. Neurodegenerative diseases: The immunological perspective. J Neuroimmunol 2017;313:109-15.
  24. Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement (N Y) 2018;4:575-90.
  25. Labzin LI, Heneka MT, Latz E. Innate Immunity and Neurodegeneration. Annu Rev Med 2018;69:437-49.
  26. Fan Z, Brooks DJ, Okello A, Edison P. An early and late peak in microglial activation in Alzheimer's disease trajectory. Brain 2017;140:792-803.
  27. Calsolaro V, Edison P. Neuroinflammation in Alzheimer's disease: Current evidence and future directions. Alzheimers Dement 2016;12:719-32.
  28. Wang J, Gu BJ, Masters CL, Wang YJ. A systemic view of Alzheimer disease - insights from amyloid-beta metabolism beyond the brain. Nat Rev Neurol 2017;13:612-23.
  29. Watad A, Bragazzi NL, Tiosano S, Yavne Y, Comaneshter D, Cohen AD, et al. Alzheimer's Disease in Systemic Sclerosis Patients: A Nationwide Population-Based Cohort Study. J Alzheimers Dis 2018;65:117-24.
  30. Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE. Pathogenesis of Systemic Sclerosis. Front Immunol 2015;6:272.
  31. Amaral TN, Peres FA, Lapa AT, Marques-Neto JF, Appenzeller S. Neurologic involvement in scleroderma: a systematic review. Semin Arthritis Rheum 2013;43:335-47.